VetCell B
VetCell Bioscience
英國VetCell Bioscience www.vetcell.com
英國VetCell 干細胞療法
VetCell Bioscience Limited is the leading provider of stem cell technology to the world of animal health. VetCell is a trading company of MedCell Bioscience Ltd and was formed in partnership with the Royal Veterinary College and the Institute for Orthopaedic and Musculoskeletal Science to develop the veterinary use of stem cell technologies.
VetCell has rapidly commercialised a technique for the multiplication of equine stem cells which can be used in the treatment of tendon and ligament injury. This service is now available to veterinary surgeons in the UK and internationally. VetCell has also developed a simple method for separating and storing stem cells from the umbilical cord of foals.
These products provide the platform from which the company will expand to provide a new globally available range of veterinary therapeutic options in cats, dogs, horses and other domestic species.
MedCell Bioscience Ltd (MedCell) is a UK based biotech company focussed on harnessing the power of stem cells to provide musculoskeletal regenerative therapeutics.
MedCell’s novel lead technologies cover cell therapy, cell expansion, and tissue scaffolds. These are three of the cornerstones of regenerative medicine address unmet needs and provide significant advantages over current practice:
MS-ten - Stem cell treatments for tendon & ligament injuries
NovaPod - Cell expansion bioprocessing systems
TheraGlass - Binary sol-gel glass technologies
MedCell’s stem cell technology has already generated international revenues and the Company has been recognised through awards for outstanding achievement in export and as a bioentrepreneurial company of the year.
The Company boasts a breadth of commercial life sciences experience and is advised by world renowned academics and clinicians.
